These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36153182)

  • 1. Can a smallpox drug treat monkeypox? Compassionate use of tecovirimat for monkeypox infection.
    Fatima M; Ahmed A; Murad MW; Afzal Z
    Eur J Intern Med; 2023 Jan; 107():105-106. PubMed ID: 36153182
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus infection.
    Berhanu A; Prigge JT; Silvera PM; Honeychurch KM; Hruby DE; Grosenbach DW
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4296-300. PubMed ID: 25896687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compassionate Use of Tecovirimat for the Treatment of Monkeypox Infection.
    Desai AN; Thompson GR; Neumeister SM; Arutyunova AM; Trigg K; Cohen SH
    JAMA; 2022 Oct; 328(13):1348-1350. PubMed ID: 35994281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Perspectives on Antimicrobial Agents: Tecovirimat for Treatment of Human Monkeypox Virus.
    DeLaurentis CE; Kiser J; Zucker J
    Antimicrob Agents Chemother; 2022 Dec; 66(12):e0122622. PubMed ID: 36374026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tecovirimat for smallpox infections.
    Bolken TC; Hruby DE
    Drugs Today (Barc); 2010 Feb; 46(2):109-17. PubMed ID: 20393639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of smallpox approved tecovirimat (Tpoxx) drug against Monkeypox: current update and futuristic prospects.
    Das T; Nandy S; Ghosh A; Chandran D; Sharma AK; Dhama K; Dey A
    Int J Surg; 2023 May; 109(5):1528-1530. PubMed ID: 36974695
    [No Abstract]   [Full Text] [Related]  

  • 7. Monkeypox treatment: Current evidence and future perspectives.
    Khani E; Afsharirad B; Entezari-Maleki T
    J Med Virol; 2023 Jan; 95(1):e28229. PubMed ID: 36253931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Treatment Delay on Efficacy of Tecovirimat Following Lethal Aerosol Monkeypox Virus Challenge in Cynomolgus Macaques.
    Russo AT; Grosenbach DW; Brasel TL; Baker RO; Cawthon AG; Reynolds E; Bailey T; Kuehl PJ; Sugita V; Agans K; Hruby DE
    J Infect Dis; 2018 Sep; 218(9):1490-1499. PubMed ID: 29982575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tecovirimat, a p37 envelope protein inhibitor for the treatment of smallpox infection.
    Duraffour S; Andrei G; Snoeck R
    IDrugs; 2010 Mar; 13(3):181-91. PubMed ID: 20191435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tecovirimat for Monkeypox in Central African Republic under Expanded Access.
    Mbrenga F; Nakouné E; Malaka C; Bourner J; Dunning J; Vernet G; Horby P; Olliaro P
    N Engl J Med; 2022 Dec; 387(24):2294-2295. PubMed ID: 36449745
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic modeling to determine the dose of ST-246 to protect against smallpox in humans.
    Leeds JM; Fenneteau F; Gosselin NH; Mouksassi MS; Kassir N; Marier JF; Chen Y; Grosenbach D; Frimm AE; Honeychurch KM; Chinsangaram J; Tyavanagimatt SR; Hruby DE; Jordan R
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1136-43. PubMed ID: 23254433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Tecovirimat for the Treatment of Smallpox.
    Grosenbach DW; Honeychurch K; Rose EA; Chinsangaram J; Frimm A; Maiti B; Lovejoy C; Meara I; Long P; Hruby DE
    N Engl J Med; 2018 Jul; 379(1):44-53. PubMed ID: 29972742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing a drug for an eradicated human disease: US Food and Drug Administration review of tecovirimat for the treatment of smallpox.
    Chan-Tack KM; Harrington PR; Choi SY; Myers L; O'Rear J; Seo S; McMillan D; Ghantous H; Birnkrant D; Sherwat AI
    Lancet Infect Dis; 2019 Jun; 19(6):e221-e224. PubMed ID: 30853252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol of Tecopox study: a multicentre, open-label, double-arm trial to evaluate the efficacy and safety of oral tecovirimat therapy for patients with smallpox or monkeypox.
    Suzuki T; Saito S; Tsuzuki S; Ashida S; Takakusaki M; Yoshikawa T; Shimojima M; Ebihara H; Ohmagari N; Morioka S
    BMJ Open; 2023 Aug; 13(8):e069550. PubMed ID: 37527886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tecovirimat: First Global Approval.
    Hoy SM
    Drugs; 2018 Sep; 78(13):1377-1382. PubMed ID: 30120738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge.
    Russo AT; Berhanu A; Bigger CB; Prigge J; Silvera PM; Grosenbach DW; Hruby D
    Vaccine; 2020 Jan; 38(3):644-654. PubMed ID: 31677948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications.
    Russo AT; Grosenbach DW; Chinsangaram J; Honeychurch KM; Long PG; Lovejoy C; Maiti B; Meara I; Hruby DE
    Expert Rev Anti Infect Ther; 2021 Mar; 19(3):331-344. PubMed ID: 32882158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of antivirals in the treatment of human monkeypox outbreaks: a systematic review.
    Shamim MA; Padhi BK; Satapathy P; Veeramachaneni SD; Chatterjee C; Tripathy S; Akhtar N; Pradhan A; Dwivedi P; Mohanty A; Rodriguez-Morales AJ; Sah R; Al-Tammemi AB; Al-Tawfiq JA; Nowrouzi-Kia B; Chattu VK
    Int J Infect Dis; 2023 Feb; 127():150-161. PubMed ID: 36470502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human monkeypox virus infection in an immunocompromised man: trial with tecovirimat.
    Hernandez LE; Jadoo A; Kirsner RS
    Lancet; 2022 Sep; 400(10355):e8. PubMed ID: 36088950
    [No Abstract]   [Full Text] [Related]  

  • 20. Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development potential.
    Russo AT; Grosenbach DW; Honeychurch KM; Long PG; Hruby DE
    Expert Rev Anti Infect Ther; 2023 Mar; 21(3):235-242. PubMed ID: 36728515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.